bayhill

Sans IPO, Bayhill secures $350M in Genentech licensing deal - VentureBeat border=

Sans IPO, Bayhill secures $350M in Genentech licensing deal - VentureBeat

VentureBeat
Months after giving up on its IPO hopes last year — when the market was especially brutal for lifescience companies — Bayhill Therapeutics has landed a …
BioWorld Online

Written on June 11, 2009 | Posted in Sports | No comment

Tags: , , , , , , , ,